Prognostic value of combining high sensitive troponin T and N-terminal pro B-type natriuretic peptide in chest pain patients with no persistent ST-elevation

Clinica Chimica Acta

Volumn 413, Issue 9-10, 2012, Pages 933-937

  Melki, Dina ^a   Lind, Suzanne ^b   Agewall, Stefan ^c   Jernberg, Tomas ^a  

^a Section of Cardiology   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Chest pain; Myocardial infarction; Natriuretic peptide; Prognosis; Troponin

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; THORAX PAIN;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHEST PAIN; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TROPONIN T;

EID: 84858621921     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.02.008     Document Type: Article

References (24)

1. Hamm C.W., Bassand J.P., Agewall S. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011, 32:2999-3054.
2. Morrow D.A., Cannon C.P., Jesse R.L., et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 2007, 115:e356-e375.
3. Thygesen K., Alpert J.S., White H.D. Universal definition of myocardial infarction. Eur Heart J 2007, 28:2525-2538.
4. James S.K., Lindahl B., Siegbahn A., et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 2003, 108:275-281.
5. Jernberg T., Stridsberg M., Venge P., Lindahl B. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 2002, 40:437-445.
6. Apple F.S., Smith S.W., Pearce L.A., Ler R., Murakami M.M. Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2008, 54:723-728.
7. Latini R., Masson S., Anand I.S., et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007, 116:1242-1249.
8. Melanson S.E., Morrow D.A., Jarolim P. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol 2007, 128:282-286.
9. Venge P., James S., Jansson L., Lindahl B. Clinical performance of two highly sensitive cardiac troponin I assays. Clin Chem 2009, 55:109-116.
10. Reichlin T., Hochholzer W., Bassetti S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009, 361:858-867.
11. Melki D., Lind S., Agewall S., Jernberg T. Diagnostic value of high sensitive troponin T in chest pain patients with no persistent ST-elevations. Scand Cardiovasc J 2011, 45:198-204.
12. Celik S., Giannitsis E., Wollert K.C. Cardiac troponin T concentrations above the 99th percentile value as measured by a new high-sensitivity assay predict long-term prognosis in patients with acute coronary syndromes undergoing routine early invasive strategy. Clin Res Cardiol 2011, 100:1077-1085.
13. Lindahl B., Venge P., James S. The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes. Am Heart J 2010, 160:224-229.
14. Ndrepepa G., Braun S., Schulz S., et al. Comparison of prognostic value of high-sensitivity and conventional troponin T in patients with non-ST-segment elevation acute coronary syndromes. Clin Chim Acta 2011, 412:1350-1356.
15. Januzzi J.L., Camargo C.A., Anwaruddin S., et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005, 95:948-954.
16. Agewall S., Giannitsis E., Jernberg T., Katus H. Troponin elevation in coronary vs. non-coronary disease. Eur Heart J 2011, 32:404-411.
17. Weber M., Bazzino O., Navarro Estrada J.L. Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. Am Heart J 2011, 162:81-88.
18. Aldous S.J., Florkowski C.M., Crozier I.G., George P., Mackay R., Than M. High sensitivity troponin outperforms contemporary assays in predicting major adverse cardiac events up to two years in patients with chest pain. Ann Clin Biochem 2010, 48:249-255.
19. Hochholzer W., Reichlin T., Twerenbold R. Incremental Value of High-Sensitivity Cardiac Troponin T for Risk Prediction in Patients with Suspected Acute Myocardial Infarction. Clin Chem 2011, 57:1318-1326.
20. Christ M., Popp S., Pohlmann H., et al. Implementation of high sensitivity cardiac troponin T measurement in the emergency department. Am J Med 2010, 123:1134-1142.
21. Giannitsis E., Becker M., Kurz K., Hess G., Zdunek D., Katus H.A. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem 2010, 56:642-650.
22. Jernberg T., James S., Lindahl B., et al. Natriuretic peptides in unstable coronary artery disease. Eur Heart J 2004, 25:1486-1493.
23. James S.K., Lindback J., Tilly J., et al. Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy. J Am Coll Cardiol 2006, 48:1146-1154.
24. Jernberg T., Lindahl B., Siegbahn A., et al. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. J Am Coll Cardiol 2003, 42:1909-1916.